An historical overview over Pharmacovigilance

Research output: Contribution to journalComment/debate

Abstract

Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years.

Original languageEnglish
Pages (from-to)744-747
Number of pages4
JournalInternational Journal of Clinical Pharmacy
Volume40
Issue number4
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Pharmacovigilance
Health
Pharmaceutical Preparations
Men's Health
Patient Safety
Registries
Odds Ratio
Quality of Life
Pharmacology

Keywords

  • Adverse drug reactions
  • History
  • Legislation
  • Pharmacovigilances
  • Signal detection
  • Thalidomide

ASJC Scopus subject areas

  • Pharmacy
  • Toxicology
  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

An historical overview over Pharmacovigilance. / Fornasier, Giulia; Francescon, Sara; Leone, Roberto; Baldo, Paolo.

In: International Journal of Clinical Pharmacy, Vol. 40, No. 4, 01.08.2018, p. 744-747.

Research output: Contribution to journalComment/debate

@article{78c1b5f0bb9d4e9792701fcb7c47b1dc,
title = "An historical overview over Pharmacovigilance",
abstract = "Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years.",
keywords = "Adverse drug reactions, History, Legislation, Pharmacovigilances, Signal detection, Thalidomide",
author = "Giulia Fornasier and Sara Francescon and Roberto Leone and Paolo Baldo",
year = "2018",
month = "8",
day = "1",
doi = "10.1007/s11096-018-0657-1",
language = "English",
volume = "40",
pages = "744--747",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - An historical overview over Pharmacovigilance

AU - Fornasier, Giulia

AU - Francescon, Sara

AU - Leone, Roberto

AU - Baldo, Paolo

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years.

AB - Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years.

KW - Adverse drug reactions

KW - History

KW - Legislation

KW - Pharmacovigilances

KW - Signal detection

KW - Thalidomide

UR - http://www.scopus.com/inward/record.url?scp=85048519778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048519778&partnerID=8YFLogxK

U2 - 10.1007/s11096-018-0657-1

DO - 10.1007/s11096-018-0657-1

M3 - Comment/debate

VL - 40

SP - 744

EP - 747

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 4

ER -